← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4.
MF Analyser

DSP Healthcare Fund

Direct Plan · Growth · Sectoral / Thematic · Scheme code 145454

NAV₹51.2810as on 25 Sep 2026
Fund houseDSP Mutual Fund
CategorySectoral / Thematic
Plan & optionDirect · Growth
History7.8 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 0.2811.2526.51 16.4821.8015.54 25.92—23.27
Nifty 500
benchmark		 0.874.312.15 5.2012.4911.41 ——15.49
Sectoral / Thematic
category median		 ——— 3.5214.6711.99 —14.72—

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fallR²
This scheme 14.1% 1.08 1.59 0.62 15.00% -21.7% 46.04
Nifty 500
benchmark		 17.2%0.35 0.47—— -37.3%—

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 83 months this scheme and its benchmark share.

Growth of ₹100 since launch

642253865472020202220242026MF Analyser

Drawdown from peak (%)

0%-8%-16%-24%2020202220242026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
331 -14.0% 20.9% 91.5% 18%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

How it behaves against its benchmark

Up captureDown captureCorrelation Tracking errorInformation ratioTreynor
99% 36% 0.68 13.9% 0.84 32.88

Up capture is how much of the benchmark's gain this scheme kept in the months the benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it on the up side is the combination every fund is trying for and few reach. Measured over the 83 months this scheme and Nifty 500 share.

MF Analyser

DSP Healthcare Fund

Direct Plan · Growth

Allocation

By asset

Equity87.90%
Foreign Securities9.22%
Cash & Equivalents2.88%

By market cap

Large Cap25.92%
Mid Cap13.81%
Small Cap44.07%
Unclassified13.32%

Concentration

Number of stocks31
Top 5 stocks37.96%
Top 10 stocks61.42%
Top 20 stocks87.82%
Lines in the filing33
Largest holding8.74%
Largest sectorPharmaceuticals & Biotechnology 67.28%
Effective stocks20.5
Sectors held5
Cash2.88%

Effective stocks is what the concentration works out to: a fund holding 31 names but most of its money in a few behaves like a fund of 21. Cash includes repo and TREPS, which every fund parks money in overnight.

Sector split

Pharmaceuticals & Biotechnology — 67.3%Healthcare Services — 20.4%Healthcare Equipment & Supplies — 7.5%Other — 4.9%Pharmaceuticals & Biotech…67.3%Healthcare Services20.4%Healthcare Equipment & Su…7.5%Other4.9%
Pharmaceuticals & Biotechnology67.28%
Healthcare Services20.36%
Healthcare Equipment & Supplies7.51%
Cash & Equivalents2.88%
Insurance0.99%
Foreign Security0.98%
MF Analyser

DSP Healthcare Fund

Direct Plan · Growth · holdings

Top 30 holdings

#CompanySectorShares held Value
₹ cr		% of fund
1 IPCA Laboratories Limited Pharmaceuticals & Biotechnology 1,696,381 335 8.74%
2 Sun Pharmaceutical Industries Limited Pharmaceuticals & Biotechnology 1,535,592 305 7.95%
3 Sai Life Sciences Limited Pharmaceuticals & Biotechnology 1,957,356 286 7.45%
4 Cipla Limited Pharmaceuticals & Biotechnology 2,001,379 282 7.35%
5 Apollo Hospitals Enterprise Limited Healthcare Services 278,729 248 6.47%
6 Gland Pharma Limited Pharmaceuticals & Biotechnology 795,267 230 5.98%
7 Globus Medical Inc Healthcare Equipment & Supplies 268,800 209 5.44%
8 Divi's Laboratories Limited Pharmaceuticals & Biotechnology 168,223 159 4.15%
9 Alkem Laboratories Limited Pharmaceuticals & Biotechnology 293,861 157 4.08%
10 Cohance Lifesciences Limited Pharmaceuticals & Biotechnology 3,202,999 146 3.81%
11 TREPS / Reverse Repo Investments Unclassified — 145 3.77%
12 Manipal Health Enterprises Limited Healthcare Services 1,859,425 142 3.70%
13 Pfizer Limited Pharmaceuticals & Biotechnology 263,627 123 3.22%
14 Alembic Pharmaceuticals Limited Pharmaceuticals & Biotechnology 1,442,516 120 3.14%
15 Kovai Medical Center And Hospital Limited Healthcare Services 176,815 107 2.80%
16 Concord Biotech Limited Pharmaceuticals & Biotechnology 735,820 106 2.77%
17 Vijaya Diagnostic Centre Limited Healthcare Services 615,708 93 2.44%
18 Procter & Gamble Health Limited Pharmaceuticals & Biotechnology 159,288 92 2.40%
19 Thyrocare Technologies Limited Healthcare Services 1,341,127 81 2.11%
20 Indoco Remedies Limited Pharmaceuticals & Biotechnology 3,245,682 79 2.06%
21 Intuitive Surgical Inc Healthcare Equipment & Supplies 18,768 68 1.76%
22 Unichem Laboratories Limited Pharmaceuticals & Biotechnology 1,128,668 63 1.64%
23 Syngene International Limited Healthcare Services 1,249,668 50 1.31%
24 Nephrocare Health Services Limited Healthcare Services 634,983 43 1.13%
25 ICICI Lombard General Insurance Co Limited Insurance 241,413 38 0.99%
26 Global X Funds - Global X Genomics & Biotechnology ETF Foreign Security 61,250 38 0.98%
27 Aarti Drugs Limited Pharmaceuticals & Biotechnology 852,155 35 0.91%
28 Abbott Laboratories Pharmaceuticals & Biotechnology 31,600 33 0.87%
29 Eris Lifesciences Limited Pharmaceuticals & Biotechnology 225,856 29 0.76%
30 Jupiter Life Line Hospitals Limited Healthcare Services 516,535 15 0.40%
MF Analyser

DSP Healthcare Fund

Direct Plan · Growth · where the money sits

What the manager did last month

Between the filings of 31 Jul 2026 and 31 Aug 2026. A position grows because the manager bought or because the price rose; only the share count separates them.

BoughtSoldNew positionsSold out ofPrice move of holdings
₹165 cr ₹85 cr 1 0 +5.57%
StockShares tradedShares PriceValue
₹ cr
New position
Thyrocare Technologies Limited 1,341,127 entered — 81.1
Added to
Divi's Laboratories Limited 62,975 +59.8% +17.5% 59.6
Apollo Hospitals Enterprise Limited 43,297 +18.4% -0.7% 38.5
Concord Biotech Limited 239,132 +48.2% +1.8% 34.6
Pfizer Limited 57,949 +28.2% -2.9% 27.2
Kovai Medical Center And Hospital Limited 8,810 +5.2% +2.8% 5.4
Unichem Laboratories Limited 4,171 +0.4% +8.4% 0.2
Trimmed
Vijaya Diagnostic Centre Limited 319,822 -34.2% +12.9% 48.6
Gland Pharma Limited 125,406 -13.6% +15.3% 36.2
Not equityPrevious filingThis filingChange
Cash, repo and TREPS ₹0 cr ₹0 cr +₹0 cr

The list above is stocks and fund units. Treasury bills, repo and money-market lines roll over every month by design — they are not decisions, so they are totalled here rather than listed as activity.

A ₹10,000 monthly SIP over five years

InvestedValueGainXIRR
₹600,000 ₹998,083 ₹398,083 20.47%

XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has been invested for a different length of time.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 27 Sep 2026.